These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 7538844)
21. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer. Miyata Y; Sakai H; Hayashi T; Kanetake H Prostate; 2003 Feb; 54(2):125-32. PubMed ID: 12497585 [TBL] [Abstract][Full Text] [Related]
22. Analysis of insulin-like growth factor binding proteins in the tammar wallaby, Macropus eugenii. Carr JM; Owens JA; Baudinette RV; Wallace JC Gen Comp Endocrinol; 1995 Jul; 99(1):50-9. PubMed ID: 7544753 [TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure. Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964 [TBL] [Abstract][Full Text] [Related]
24. Expression and characterization of a serine protease that preferentially cleaves insulin-like growth factor binding protein-5. Hou J; Clemmons DR; Smeekens S J Cell Biochem; 2005 Feb; 94(3):470-84. PubMed ID: 15534875 [TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor binding protein (IGFBP)-3 levels in conditioned media of Hs578T human breast cancer cells are post-transcriptionally regulated. Oh Y; Müller HL; Pham H; Lamson G; Rosenfeld RG Growth Regul; 1993 Mar; 3(1):84-7. PubMed ID: 7683543 [TBL] [Abstract][Full Text] [Related]
26. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients? Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646 [TBL] [Abstract][Full Text] [Related]
27. Calpain proteolysis of insulin-like growth factor binding protein (IGFBP) -2 and -3, but not of IGFBP-1. Berg U; Bang P; Carlsson-Skwirut C Biol Chem; 2007 Aug; 388(8):859-63. PubMed ID: 17655506 [TBL] [Abstract][Full Text] [Related]
28. Proteolysis of insulin-like growth factor-binding protein-3 in the male reproductive tract. Plymate SR; Rosen CJ; Paulsen CA; Ware JL; Chen J; Vessella RE; Birnbaum RS J Clin Endocrinol Metab; 1996 Feb; 81(2):618-24. PubMed ID: 8636278 [TBL] [Abstract][Full Text] [Related]
29. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. Cohen P; Graves HC; Peehl DM; Kamarei M; Giudice LC; Rosenfeld RG J Clin Endocrinol Metab; 1992 Oct; 75(4):1046-53. PubMed ID: 1383255 [TBL] [Abstract][Full Text] [Related]
30. Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins. Roghani M; Lassarre C; Zapf J; Povoa G; Binoux M J Clin Endocrinol Metab; 1991 Sep; 73(3):658-66. PubMed ID: 1714916 [TBL] [Abstract][Full Text] [Related]
31. 7S nerve growth factor is an insulin-like growth factor-binding protein protease. Rajah R; Bhala A; Nunn SE; Peehl DM; Cohen P Endocrinology; 1996 Jul; 137(7):2676-82. PubMed ID: 8770886 [TBL] [Abstract][Full Text] [Related]
32. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. Cohen P; Peehl DM; Graves HC; Rosenfeld RG J Endocrinol; 1994 Sep; 142(3):407-15. PubMed ID: 7525824 [TBL] [Abstract][Full Text] [Related]
33. Characterization of truncated insulin-like growth factor-binding protein-2 in human milk. Ho PJ; Baxter RC Endocrinology; 1997 Sep; 138(9):3811-8. PubMed ID: 9275069 [TBL] [Abstract][Full Text] [Related]
34. Activity of human pregnancy insulin-like growth factor binding protein-3: determination by reconstituting recombinant complexes. Yan X; Payet LD; Baxter RC; Firth SM Endocrinology; 2009 Nov; 150(11):4968-76. PubMed ID: 19734278 [TBL] [Abstract][Full Text] [Related]
35. A central domain binding site in insulin-like growth factor binding protein-5 for the acid-labile subunit. Twigg SM; Kiefer MC; Zapf J; Baxter RC Endocrinology; 2000 Jan; 141(1):454-7. PubMed ID: 10614670 [TBL] [Abstract][Full Text] [Related]
36. Identification of IGFBP-3 fragments generated by KLK2 and prevention of fragmentation by KLK2-inhibiting peptides. Hekim C; Riipi T; Weisell J; Närvänen A; Koistinen R; Stenman UH; Koistinen H Biol Chem; 2010 Apr; 391(4):475-9. PubMed ID: 20180640 [TBL] [Abstract][Full Text] [Related]
37. Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor. Vorwerk P; Hohmann B; Oh Y; Rosenfeld RG; Shymko RM Endocrinology; 2002 May; 143(5):1677-85. PubMed ID: 11956149 [TBL] [Abstract][Full Text] [Related]
38. O-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis. Marinaro JA; Neumann GM; Russo VC; Leeding KS; Bach LA Eur J Biochem; 2000 Sep; 267(17):5378-86. PubMed ID: 10951195 [TBL] [Abstract][Full Text] [Related]
39. Prostate-specific antigen and other prostate-derived proteases cleave IGFBP-3, but prostate cancer is not associated with proteolytically cleaved circulating IGFBP-3. Koistinen H; Paju A; Koistinen R; Finne P; Lövgren J; Wu P; Seppälä M; Stenman UH Prostate; 2002 Feb; 50(2):112-8. PubMed ID: 11816019 [TBL] [Abstract][Full Text] [Related]
40. Validation of functional insulin-like growth factor binding protein-3 measurement by a ligand immunoassay. Langkamp M; Weber K; Kirschner M; Pridzun L; Ranke MB Clin Lab; 2010; 56(11-12):535-42. PubMed ID: 21141437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]